This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coulier, F Articles by Barbacid, M Search for Related Content PubMed PubMed Citation Articles by Coulier, F Articles by Barbacid, M

 Previous Article  |  Next Article 

Mol Cell Biol. 1990 August; 10(8): 4202-4210

Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain.

F Coulier, R Kumar, M Ernst, R Klein, D Martin-Zanca and M Barbacid

BRI-Basic Research Program, National Cancer Institute-Frederick Cancer Research Facility, Maryland 21701.

ABSTRACT

Malignant activation of the human trk proto-oncogene, a member of the tyrosine protein kinase receptor family, has been implicated in the development of certain human cancers, including colon and thyroid papillary carcinomas. trk oncogenes have also been identified in cultured cells transfected with various DNAs. In this study, we report the characterization of three in vitro-generated trk oncogenes, trk2, trk4, and trk5 (R. Oskam, F. Coulier, M. Ernst, D. Martin-Zanca, and M. Barbacid, Proc. Natl. Acad. Sci. USA 85:2964-2968, 1988), in an effort to understand the spectrum of mutational events that can activate the human trk gene. Nucleotide sequence analysis of cDNA clones of trk2 and trk4 revealed that these oncogenes were generated by a head-to-tail arrangement of two trk tyrosine protein kinase domains connected by a purine-rich region. These oncogenes code for cytoplasmic molecules of 67,000 (p67trk2) and 69,000 (p69trk4) daltons. In contrast, the product of the trk5 oncogene, gp95trk5, is a cell surface glycoprotein of 95,000 daltons. This oncogene was generated by a 153-base-pair in-frame deletion within sequences coding for the extracellular domain of the trk receptor. This activating deletion encompasses a triplet coding for one of the nine cysteine residues that the trk receptor shares with the product of the highly related trkB tyrosine protein kinase gene. Introduction of a single point mutation (TGT----AGT) in this codon resulted in a novel trk oncogene whose product, gp140S345, differs from the nontransforming trk proto-oncogene receptor in a single amino acid residue, Ser-345 instead of Cys-345. These results illustrate that multiple molecular mechanisms, including point mutation, internal deletion, and kinase domain duplication, can result in the malignant activation of the human trk proto-oncogene.

---

Mol Cell Biol. 1990 August; 10(8): 4202-4210

This article has been cited by other articles:

• Li, Z., Beutel, G., Rhein, M., Meyer, J., Koenecke, C., Neumann, T., Yang, M., Krauter, J., von Neuhoff, N., Heuser, M., Diedrich, H., Gohring, G., Wilkens, L., Schlegelberger, B., Ganser, A., Baum, C. (2009). High-affinity neurotrophin receptors and ligands promote leukemogenesis. Blood 113: 2028-2037 [Abstract] [Full Text]  
• Vidal, F, Lopez, P, Lopez-Fernandez, L., Ranc, F, Scimeca, J., Cuzin, F, Rassoulzadegan, M (2001). Gene trap analysis of germ cell signaling to Sertoli cells: NGF-TrkA mediated induction of Fra1 and Fos by post-meiotic germ cells. J. Cell Sci. 114: 435-443 [Abstract]  
• Reuther, G. W., Lambert, Q. T., Caligiuri, M. A., Der, C. J. (2000). Identification and Characterization of an Activating TrkA Deletion Mutation in Acute Myeloid Leukemia. Mol. Cell. Biol. 20: 8655-8666 [Abstract] [Full Text]  
• Arevalo, J. C., Conde, B., Hempstead, B. L., Chao, M. V., Martin-Zanca, D., Perez, P. (2000). TrkA Immunoglobulin-Like Ligand Binding Domains Inhibit Spontaneous Activation of the Receptor. Mol. Cell. Biol. 20: 5908-5916 [Abstract] [Full Text]  
• Zhang, Y.-z., Moheban, D. B., Conway, B. R., Bhattacharyya, A., Segal, R. A. (2000). Cell Surface Trk Receptors Mediate NGF-Induced Survival While Internalized Receptors Regulate NGF-Induced Differentiation. J. Neurosci. 20: 5671-5678 [Abstract] [Full Text]  
• Maliartchouk, S., Debeir, T., Beglova, N., Cuello, A. C., Gehring, K., Saragovi, H. U. (2000). Genuine Monovalent Ligands of TrkA Nerve Growth Factor Receptors Reveal a Novel Pharmacological Mechanism of Action. J. Biol. Chem. 275: 9946-9956 [Abstract] [Full Text]  
• Chittka, A., Chao, M. V. (1999). Identification of a zinc finger protein whose subcellular distribution is regulated by serum and nerve growth factor. Proc. Natl. Acad. Sci. USA 96: 10705-10710 [Abstract] [Full Text]  
• Cosma, M. P., Cardone, M., Carlomagno, F., Colantuoni, V. (1998). Mutations in the Extracellular Domain Cause RET Loss of Function by a Dominant Negative Mechanism. Mol. Cell. Biol. 18: 3321-3329 [Abstract] [Full Text]  
• Ninkina, N., Grashchuck, M., Buchman, V. L., Davies, A. M. (1997). TrkB Variants with Deletions in the Leucine-rich Motifs of the Extracellular Domain. J. Biol. Chem. 272: 13019-13025 [Abstract] [Full Text]  
• Windisch, Jör. M., Marksteiner, R., Schneider, R. (1995). Nerve Growth Factor Binding Site on TrkA Mapped to a Single 24-Amino Acid Leucine-rich Motif. J. Biol. Chem. 270: 28133-28138 [Abstract] [Full Text]  
• Benito, M, Porras, A, Nebreda, A., Santos, E (1991). Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes. Science 253: 565-568 [Abstract]  
• Nebreda, A., Martin-Zanca, D, Kaplan, D., Parada, L., Santos, E (1991). Induction by NGF of meiotic maturation of Xenopus oocytes expressing the trk proto-oncogene product. Science 252: 558-561 [Abstract]  
• Zaccaro, M. C., Ivanisevic, L., Perez, P., Meakin, S. O., Saragovi, H. U. (2001). p75 Co-receptors Regulate Ligand-dependent and Ligand-independent Trk Receptor Activation, in Part by Altering Trk Docking Subdomains. J. Biol. Chem. 276: 31023-31029 [Abstract] [Full Text]